文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

流感病毒感染患者住院与死亡的危险因素:系统评价与Meta分析

Risk factors for hospital admission and mortality in patients with influenza virus infection: a systematic review and meta-analysis.
PubMed 文献 · Lancet Respir Med · 2026-09-08
一句话结论非重症流感住院的主要危险因素包括高龄、免疫抑制、心血管病、神经疾病和慢性呼吸病;重症流感死亡的主要危险因素包括继发细菌感染、营养不良、脓毒症和急性肾损伤。

该研究为支持世界卫生组织(WHO)流感临床指南更新而开展的系统评价与Meta分析,检索2000年1月1日至2025年10月30日的观察性研究,最终纳入63项研究、2 150 518名实验室确诊季节性流感患者。在非重症流感患者中,中等或高确定性证据显示高龄(成人每增加10岁OR 1.72)、心血管疾病(OR 2.72)、HIV/免疫缺陷/免疫抑制(OR 2.70)、慢性呼吸疾病(OR 2.24)和任何神经系统疾病(OR 2.31)是住院的主要危险因素。在重症流感患者中,继发细菌感染(OR 4.13)、营养不良(OR 3.29)、脓毒症(OR 3.19)、急性肾损伤(OR 2.92)、年龄≥65岁(OR 2.47)等是全因死亡的主要危险因素。作者认为这些发现支持对季节性流感进行风险分层和针对性防治。

要点

  • 非重症流感住院的主要危险因素(中等或高确定性证据):高龄(成人每增加10岁OR 1.72,95%CI 1.02-2.89)、心血管疾病(OR 2.72,95%CI 1.24-5.94)、HIV/免疫缺陷/免疫抑制(OR 2.70,95%CI 1.55-4.70)。
  • 非重症流感住院的附加危险因素:妊娠(OR 1.88,95%CI 1.73-2.05)、糖尿病(OR 1.84,95%CI 1.26-2.67)、恶性肿瘤(OR 1.75,95%CI 1.12-2.75)。
  • 重症流感全因死亡的主要危险因素(中等或高确定性证据):继发细菌感染(OR 4.13,95%CI 1.53-11.14)、营养不良(OR 3.29,95%CI 1.57-6.89)、脓毒症(OR 3.19,95%CI 2.08-4.89)、急性肾损伤(OR 2.92,95%CI 1.11-7.73)。
  • 重症流感全因死亡的附加危险因素:任何肝脏疾病(OR 1.86,95%CI 1.35-2.58)、HIV/免疫缺陷/免疫抑制(OR 1.79,95%CI 1.51-2.13)、慢性阻塞性肺疾病(OR 1.74,95%CI 1.37-2.20)。
  • 作者认为这些发现支持对季节性流感进行风险分层和针对性防治策略。

适用人群与场景

  • 任何年龄的实验室确诊季节性流感患者,纳入的63项研究平均年龄范围3.6-87.9岁。
  • 非重症流感患者(用于评估住院危险因素)和重症流感患者(用于评估全因死亡危险因素)。

研究设计与关键结果

  • 研究类型:系统评价与Meta分析,纳入63项观察性研究,共2 150 518名参与者。
  • 非重症流感住院主要危险因素(中等或高确定性证据):高龄(成人每增加10岁OR 1.72,95%CI 1.02-2.89)、心血管疾病(OR 2.72,95%CI 1.24-5.94)、HIV/免疫缺陷/免疫抑制(OR 2.70,95%CI 1.55-4.70)、慢性呼吸疾病(OR 2.24,95%CI 1.90-2.64)、任何神经系统疾病(OR 2.31,95%CI 1.65-3.24)。
  • 非重症流感住院附加危险因素:妊娠(OR 1.88,95%CI 1.73-2.05)、糖尿病(OR 1.84,95%CI 1.26-2.67)、恶性肿瘤(OR 1.75,95%CI 1.12-2.75)。
  • 重症流感全因死亡主要危险因素(中等或高确定性证据):继发细菌感染(OR 4.13,95%CI 1.53-11.14)、营养不良(OR 3.29,95%CI 1.57-6.89)、脓毒症(OR 3.19,95%CI 2.08-4.89)、急性肾损伤(OR 2.92,95%CI 1.11-7.73)、年龄≥65岁(OR 2.47,95%CI 2.21-2.75)、慢性心血管疾病(OR 2.43,95%CI 1.16-5.09)、恶性肿瘤(OR 2.21,95%CI 1.31-3.72)、慢性神经系统疾病(OR 2.08,95%CI 1.13-3.83)。
  • 重症流感全因死亡附加危险因素:任何肝脏疾病(OR 1.86,95%CI 1.35-2.58)、HIV/免疫缺陷/免疫抑制(OR 1.79,95%CI 1.51-2.13)、慢性阻塞性肺疾病(OR 1.74,95%CI 1.37-2.20)。

证据类型、等级与局限

  • 证据类型:系统评价与Meta分析,采用逆方差随机效应模型,使用GRADE方法评估证据确定性。
  • 方案注册于PROSPERO,注册号CRD42024535669。
  • 局限:原文未报告局限性

对床旁实践的改变

  • 作者认为这些发现支持对季节性流感进行风险分层和针对性防治策略。

指南或共识出处

  • 世界卫生组织(WHO)流感临床指南更新(原文提及该研究用于支持WHO流感临床指南更新)。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Identifying risk factors associated with hospital admission and mortality in patients with influenza is crucial for guiding clinical management and public health strategies. To support an update of WHO influenza clinical guidelines, this systematic review and meta-analysis assessed risk factors for hospital admission and all-cause mortality in patients with seasonal influenza.

METHODS: We systematically searched Medline, Embase, Cochrane Central Register of Controlled Trials, Cumulative Index to Nursing and Allied Health Literature, and Global Health for observational studies published from Jan 1, 2000, until Oct 30, 2025, that enrolled patients of any age with laboratory-confirmed seasonal influenza and reported an adjusted effect estimate for the association between at least one risk factor and hospital admission or all-cause mortality, or both. We conducted inverse-variance random-effects model meta-analyses to summarise the evidence and assessed the certainty of evidence using the GRADE approach. We registered the protocol with PROSPERO, CRD42024535669.

FINDINGS: We identified 35 808 records, of which 63 studies enrolling 2 150 518 participants (mean age 3·6-87·9 years) were eligible. In patients with non-severe influenza, evidence with moderate or high certainty showed that older age (odds ratio 1·72 per 10-year increase for adults [95% CI 1·02-2·89]); cardiovascular disease (2·72 [1·24-5·94]); HIV, immunodeficiency, or immunosuppression (2·70 [1·55-4·70]); chronic respiratory disease (2·24 [1·90-2·64]); and any neurological disease (2·31 [1·65-3·24]) were major risk factors for hospital admission-pregnancy (1·88 [1·73-2·05]), diabetes (1·84 [1·26-2·67]), and malignancy (1·75 [1·12-2·75]) were additional risk factors for hospital admission. In patients with severe influenza, evidence with moderate or high certainty showed that secondary bacterial infection (4·13 [1·53-11·14]), malnutrition (3·29 [1·57-6·89]), sepsis (3·19 [2·08-4·89]), acute kidney injury (2·92 [1·11-7·73]), age 65 years or older (2·47 [2·21-2·75]), chronic cardiovascular disease (2·43 [1·16-5·09]), malignancy (2·21 [1·31-3·72]), and chronic neurological disease (2·08 [1·13-3·83]) were major risk factors for all-cause mortality-any liver disease (1·86 [1·35-2·58]); HIV, immunodeficiency, or immunosuppression (1·79 [1·51-2·13]), and chronic obstructive pulmonary disease (1·74 [1·37-2·20]) were additional risk factors for all-cause mortality.

INTERPRETATION: Age 65 years or older, immunocompromised status, cardiovascular disease, neurological disease, and chronic respiratory disease are major risk factors for hospital admission in patients with non-severe seasonal influenza. Secondary bacterial infection, malnutrition, sepsis, acute kidney injury, age 65 years or older, chronic cardiovascular disease, malignancy, and chronic neurological disease are major risk factors for all-cause mortality in patients with severe seasonal influenza. Our findings support risk stratification and targeted prevention and treatment strategies for seasonal influenza.

来源:Lancet Respir Med,查看原文。版权归原作者所有。

参考来源

  1. Gao Y, Liu M, Uyeki TM, et al. Risk factors for hospital admission and mortality in patients with influenza virus infection: a systematic review and meta-analysis. Lancet Respir Med. 2026. PMID: 42710513. doi:10.1016/S2213-2600(26)00195-5

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。